Skip to Main Content

Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature (ELEGANCE)

Conditions

Diseases of the Cardiovascular System

What is the purpose of this trial?

The ELEGANCE Registry's objective is to collect Real-World Data (RWD), including populations previously not represented in Peripheral Vascular Disease (PVD) trials, health economics data, and to support the safe use of commercially available Boston Scientific Corporation (BSC) drug-eluting devices for the treatment of lesions located in the peripheral vasculature.

  • Trial with
    Boston Scientific Corporation
  • Start Date
    01/27/2022
  • End Date
    01/01/2028

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    02/15/2022
  • Study HIC
    #2000031921REG